Published Patent: ANTI-INFLUENZA COMPOUNDS
| Title | ANTI-INFLUENZA COMPOUNDS |
|---|---|
| Priority Date | 2009-02-04 US 12/866118 2008-02-05 US 12/026167P 2009-02-04 PCT/CA2009000133 |
| Inventors | Jones, S Lau, ASY An, JH Law, HY Lee, DCW Poon, LLM |
| Issue Date | 2009 |
| Citation | US Published patent application US 20110009369. Washington, DC: US Patent and Trademark Office (USPTO), 2011 [How to Cite?] |
| Abstract | The present invention provides pyrimidinyl compounds of formula (I) and pharmaceutically acceptable salts thereof. These compounds may be used for the inhibition of influenza. In particular, the compounds of the invention may be used for the treatment or prophylaxis of influenza A, most particularly H1N1 or H5N1 influenza. The compounds of the invention can also be used for the treatment or prophylaxis of a disease caused by Vibrio cholerae, Clostridium perfringens, Streptococcus pneumoniae, Arthrobacter sialophilus, an orthomyxovirus, a paramyxovirus, a parainfluenza virus, mumps virus, Newcastle disease virus, fowl plague virus or Sendai virus. |
| dc.contributor.inventor | Jones, S |
|---|---|
| dc.contributor.inventor | Lau, ASY |
| dc.contributor.inventor | An, JH |
| dc.contributor.inventor | Law, HY |
| dc.contributor.inventor | Lee, DCW |
| dc.contributor.inventor | Poon, LLM |
| dc.date.accessioned | 2010-07-13T04:01:35Z |
| patents.date.application | 2009-02-04 |
| dc.date.available | 2010-07-13T04:01:35Z |
| dc.date.issued | 2009 |
| patents.date.priority | 2009-02-04 US 12/866118 |
| patents.date.priority | 2008-02-05 US 12/026167P |
| patents.date.priority | 2009-02-04 PCT/CA2009000133 |
| patents.date.publication | 2011-01-13 |
| dc.description.abstract | The present invention provides pyrimidinyl compounds of formula (I) and pharmaceutically acceptable salts thereof. These compounds may be used for the inhibition of influenza. In particular, the compounds of the invention may be used for the treatment or prophylaxis of influenza A, most particularly H1N1 or H5N1 influenza. The compounds of the invention can also be used for the treatment or prophylaxis of a disease caused by Vibrio cholerae, Clostridium perfringens, Streptococcus pneumoniae, Arthrobacter sialophilus, an orthomyxovirus, a paramyxovirus, a parainfluenza virus, mumps virus, Newcastle disease virus, fowl plague virus or Sendai virus. |
| patents.description.assignee | BRITISH COLUMBIA CANCER AGENCY BRANCH [CA] |
| patents.description.cc | US |
| patents.description.country | United States of America |
| patents.description.kind | A1 |
| patents.identifier.application | US 12/866118 |
| dc.identifier.citation | US Published patent application US 20110009369. Washington, DC: US Patent and Trademark Office (USPTO), 2011 [How to Cite?] |
| dc.identifier.hkuros | 161136 |
| patents.identifier.publication | US 20110009369 |
| dc.identifier.uri | http://hdl.handle.net/10722/62454 |
| dc.language | eng |
| patents.relation.family | CA 2713848 (A1) 2009-08-13 |
| patents.relation.family | WO 2009097682 (A1) 2009-08-13 |
| dc.rights | Creative Commons: Attribution 3.0 Hong Kong License For Public Patent Documents |
| dc.title | ANTI-INFLUENZA COMPOUNDS |
| dc.type | Patent |
| patents.type | Patent_published |